YMAGUS Trademark

Trademark Overview


On Monday, November 14, 2011, a trademark application was filed for YMAGUS with the United States Patent and Trademark Office. The USPTO has given the YMAGUS trademark a serial number of 85471486. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 13, 2015. This trademark is owned by Novartis AG. The YMAGUS trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; Anti-inflammatories; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for the treatment and prevention of disorders of the metabolic system, the musculo-skeletal system, the genitourinary system and for the treatment of inflammatory disorders; pharmaceutical preparations for use in oncology and hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of gastroenterological disorders; Pharmaceutical products for ophthalmological use; Pharma...
ymagus

General Information


Serial Number85471486
Word MarkYMAGUS
Filing DateMonday, November 14, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 13, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 17, 2012

Trademark Statements


Goods and ServicesAnti-infectives; Anti-inflammatories; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for the treatment and prevention of disorders of the metabolic system, the musculo-skeletal system, the genitourinary system and for the treatment of inflammatory disorders; pharmaceutical preparations for use in oncology and hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of gastroenterological disorders; Pharmaceutical products for ophthalmological use; Pharmaceutical products for treating respiratory diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 17, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events


Event DateEvent Description
Monday, July 13, 2015ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, July 13, 2015ABANDONMENT - NO USE STATEMENT FILED
Tuesday, January 13, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, January 11, 2015EXTENSION 5 GRANTED
Thursday, December 11, 2014EXTENSION 5 FILED
Thursday, December 11, 2014TEAS EXTENSION RECEIVED
Thursday, June 19, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 18, 2014EXTENSION 4 GRANTED
Wednesday, June 11, 2014EXTENSION 4 FILED
Wednesday, June 11, 2014TEAS EXTENSION RECEIVED
Wednesday, December 18, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 17, 2013EXTENSION 3 GRANTED
Friday, December 6, 2013EXTENSION 3 FILED
Friday, December 6, 2013TEAS EXTENSION RECEIVED
Thursday, July 11, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 10, 2013EXTENSION 2 GRANTED
Saturday, June 8, 2013EXTENSION 2 FILED
Friday, June 28, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Saturday, June 8, 2013TEAS EXTENSION RECEIVED
Saturday, December 8, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 6, 2012EXTENSION 1 GRANTED
Thursday, December 6, 2012EXTENSION 1 FILED
Thursday, December 6, 2012TEAS EXTENSION RECEIVED
Tuesday, June 12, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 17, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 17, 2012PUBLISHED FOR OPPOSITION
Wednesday, March 28, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, March 9, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, March 9, 2012ASSIGNED TO LIE
Tuesday, February 21, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 21, 2012ASSIGNED TO EXAMINER
Thursday, November 17, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, November 17, 2011NEW APPLICATION ENTERED IN TRAM